Share on StockTwits

National Health Investors (NYSE:NHI) announced its earnings results on Tuesday. The company reported $0.90 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.88 by $0.02, reports. The company had revenue of $32.79 million for the quarter, compared to the consensus estimate of $31.72 million.

National Health Investors (NYSE:NHI) opened at 61.82 on Tuesday. National Health Investors has a 52-week low of $53.01 and a 52-week high of $72.99. The stock’s 50-day moving average is $59.93 and its 200-day moving average is $59.21. The company has a market cap of $1.723 billion and a price-to-earnings ratio of 14.48.

The company also recently announced a quarterly dividend, which is scheduled for Friday, May 9th. Shareholders of record on Monday, March 31st will be paid a dividend of $0.77 per share. This represents a $3.08 annualized dividend and a dividend yield of 4.98%. The ex-dividend date is Thursday, March 27th. This is a positive change from National Health Investors’s previous quarterly dividend of $0.74.

A number of research firms have recently commented on NHI. Analysts at Zacks downgraded shares of National Health Investors from an “outperform” rating to a “neutral” rating in a research note on Tuesday, February 4th. They now have a $65.10 price target on the stock. On the ratings front, analysts at Bank of America initiated coverage on shares of National Health Investors in a research note on Thursday, December 5th. They set a “neutral” rating and a $61.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $63.03.

National Health Investors, Inc (NYSE:NHI) is a self-managed real estate investment trust (REIT), which invests in income-producing healthcare properties primarily in the long-term care and senior housing industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.